chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I thought I was having a heart attack; I had severe left arm pain; I didn't get much sleep that night; This is a spontaneous report from a contactable consumer (patient). An 86-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6206), via an unspecified route of administration at left upper arm on 08Mar2021 at single dose for COVID-19 immunization. Medical history included atrial fibrillation (AFib) and high blood pressure. Concomitant medications included unspecified medications. The patient was taking loads of medications. The patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not provided) at the age of 86-years-old, via an unspecified route of administration on 08Feb2021 at single dose for COVID-19 immunization and reported that he had no problems with the first dose. The patient experienced severe left arm pain at the arm where the shot was given on 08Mar2021, the night after he received his second COVID vaccine dose. He almost called a number because he thought he was having a heart attack. What he did was he got up to walk around and the pain went away and when he sat down on his recliner, the pain came back so he didn't get much sleep that night. He was fine the next day. The patient took an ASPIRIN 325 mg coated pill because he thought he might be having a heart attack. If he had known, he would have taken the vaccine on his right arm. His arm hurt the night of 08Mar2021 until 6:00 AM the following day. The patient then stated that his recommendation was to tell the people who are administering the shot that a left arm pain may possibly occur because anybody who has the left arm hurting is afraid and can think they have a heart attack. The outcome of the event pain in arm was recovered on 09Mar2021 at 06:00 AM, and recovered on 09Mar2021 for all other events.
Client reports she received a TDAP vaccine on 9/8/2021, reports her arm was sore for a couple days after, then on 9/11/2021 her arm became red and warm to the touch, she reports the area of redness was from her shoulder to her elbow, reports going to the emergency room on 9/12/2021, reports ER doctor looked at site and did an ultrasound and told client it was a normal reaction,  client reports the next day 9/13/2021 the area of redness had spread and she was feeling worse, reports she then went to a local medical provider, reports she was also experiencing pain, and weakness in that arm, reports she could not lift her arm to even dress herself for a few days,  reports doctor prescribed an antibiotic-Keflex, reports she was also: "babbling and felt "brain dead" for a few days, reports sleeping for "46 out of 48 hours during this time", reports she also had edema during this time, does report that she gets edema at times and has a prescription for lasix that she takes,  reports she started the antibiotics on 9/14/2021, reports the redness decreased a couple days later,  reports her strength increased and pain decreased, client reports that redness is gone, reports confusion is now better
Patient states he has soreness in the injection arm, which is common. The soreness then moved down his body and into his legs. He said it felt like his legs were dead weight. Then he felt like he was having heart palpitations.
Fluttering of the heart; Gassy; A spontaneous report was received from a consumer concerning a 67-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events fluttering of the heart/cardiac flutter, and gassy/flatulence.  The patient's current condition included mitral prolapse. Concomitant medications included olmesartan medoxomil and carvedilol.  On 5 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) in the right arm for prophylaxis of COVID-19 infection.  The patient experienced the events fluttering of the heart, gassy on the evening of 05 Feb 2021 and the next day 06 Feb 2021 as well.  Treatment details included gas medication, bananas and electrolytes.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, fluttering of the heart, gassy was unknown.; Reporter's Comments: Very limited information regarding rest of the events has been provided at this time. Further information has been requested.
Patient had onset of fever, myalgias & headache within several hours of vaccine. Temp has persisted up to 103 - subsequently diagnosed with left lower lobe pneumonia - failed outpatient antibiotics - admitted x 24 hrs for IV antibiotics.
no other AE occurred; the product was administered on 9/23/2022 and the dose was expired.; This spontaneous report was received from a registered nurse (RN), concerning a patient of unknown age and gender.   Information regarding the patient's medical history, concurrent conditions, drug reactions or allergies, and concomitant therapies was not provided.  On 23-SEP-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 1 dose, lot #1742465, expiration date: 21-SEP-2022, (dose, route of administration, and anatomical location were not provided) administered orally for prophylaxis (expired product administered).
Dizziness/ Light headed - started when got home.  Has continued now for 36 hours.
red blotch - broken blood vessel on white of right eye; This is a spontaneous report from a non-contactable consumer (patient). A 39-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: El9266) on left arm, via an unspecified route of administration on 22Feb2021 18:00 at single dose for COVID-19 immunisation. Medical history included COVID from an unspecified date (if COVID prior vaccination: yes). The patient's concomitant medications were not reported. The patient experienced red blotch - broken blood vessel on white of right eye on 23Feb2021 07:00. The patient had no other vaccine in four weeks. The patient was not COVID tested post vaccination. There was no treatment received for the adverse event. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Within 24 hours, patient developed a 104 degree fever, severe lethargy,  nausea and stomach pain, headache, chills, and decreased appetite.  His fever was maintained with Ibuprofen and alleviated within 48 hours.  However, he still complains of feeling generally sick with a headache and severe cold symptoms one week later.  He had no prior health conditions and has never contracted COVID-19.  However, he now has anxiety about receiving the scheduled second dose since he has never been more sick from any actual illness in his life.
Information has been received from a healthcare worker (medical assistant) referring to unspecified patients of unknown age and gender. There was no concurrent condition or medical history reported. The healthcare worker reported that doses of VARIVAX (lot # L000453, expiry date 06-JAN-2017; lot # K015972, expiry date 23-SEP-2016; lot # J013900, expiry date 30-OCT-2015; lot # K002930, expiry date 26-FEB-2016) which were exposed to temperatures outside of the recommended range, have been administered to the unspecified patients on unspecified dates since 20-JUL-2015. At the time of this report, no adverse experience was reported. This is one of several reports received from the same reporter. Additional information has been requested.
I began feeling nauseated and tired the afternoon of the day I was vaccinated.  I ran a fever overnight.  Extreme diarrhea and nausea set in the next morning for 5-6 hrs.  Then I was fatigued for a couple of days.  7 days laterI experienced extreme bloating and pain unlike I have every experienced before.  I could not stand upright.  This was the beginning of problems with nausea, extreme gas and bloating, and periodic bouts of diarrhea.  Prior to this I tended to be constipated more often than not. I was treated initially with Flagyl thinking this was food or water-borne.  This improved symptoms but did not make it go away.  The systems returned even worse once the meds were discontinued.  About 2 weeks later the pain became so acute that I went to urgent care on the advise of the on-call doctor as he feared it was appendicitus or something equally awful.  They prescribed a broad spectrum antibiotic and large doses of Gas-X.  This calmed things down but I basically lived on yogurt and Gas-X for the next month.  I lost at least 5 lbs in the course of this illness.  Eventually my gut settled down and I was able to return to a normal diet and my normal bowel habits. I finally was able to see Dr. about 4-6 weeks ago.  He listened to the details of my experience and informed me that he felt the vaccine set off some type of response in my colon, maybe a bacterial overgrowth of some type due to the effect of the vaccination on my immune system.  He suggested that I should take a Pfizer booster when required to see if I could avoid a repeat experience.
Copy of 10/16/18 Triage call Encounter: Call returned to patient; Presenting Concern: Patient is calling to inform had SHINGRIX vaccine and Flu vaccine 10/15/18 1115. Onset of s/s of Yesterday 1300 sore shoulders, shivering-fever last night 102-feels feverish today but not feeling hot like last night. Has not taken temp today. HA and pain down back of head and back of neck (Able to touch chin to chest). Reports mild swelling face, lips, puffy around eyes but much better now since this morning when has much more swelling. Also nausea-no appetite-has not eaten today. Trying to drink water-1 glass water today. Has not taken an antihistamine. Does not have any on hand. Denies: Difficulty swallowing, tongue swelling, SOB, CP, rash, hives. Husband is on the way home. PLAN: Patient will have husband stop on way home to purchase antihistamine and then transport to closest ER. Patient has been instructed twice to call 911 with any increased swelling, difficulty swallowing, SOB, CP, onset of hives. Call placed to ER; RN. Member and or family advised to call back if symptoms worsen, do not improve, or if new symptoms develop or if has any further questions or concerns. The above individual verbalized understanding the advice given and agrees with the plan. Dr. informed verbally. Agrees with counsel provided. Added entry 10/30/18: Patient had reported that she did not go to the ED but symptoms did resolve.
Fatigue starting at 22:00 Impaired night vision starting at 0500 1/9/22 Rigors starting at 0500 1/9/21 Neuropathy in the hands starting at 0500 1/9/21
I started to cramp in my left arm then the cramps went to my left leg after that the cramps went at the bottom of my stomach. 1041 called Dr and watch pt closely. Pt encouraged to take IBU
Fatique, chills, sore arm.  Sore arm lasted 1 day.  Chills lasted 1 day.  Fatigue lasted 7 days.
Started day after vaccinated with being dizzy and nauseous, one week after vaccinated and still having the side effects. Never any issues with health prior to vaccinated.
soreness on arm; spot was hot to touch; redness on arm/spreading down the arm a little bit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness on arm), FEELING HOT (spot was hot to touch) and VACCINATION SITE ERYTHEMA (redness on arm/spreading down the arm a little bit) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness on arm), FEELING HOT (spot was hot to touch) and VACCINATION SITE ERYTHEMA (redness on arm/spreading down the arm a little bit). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (soreness on arm), FEELING HOT (spot was hot to touch) and VACCINATION SITE ERYTHEMA (redness on arm/spreading down the arm a little bit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.     Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up information received on 07-JUN-2021 contains non-significant information.
HCP has no further AE information; HCP called to report a TE for ROTATEQ, and MMR II. HCP reports that there were multiple doses given on unspecified dates to multiple patients.; HCP called to report a TE for ROTATEQ, and MMR II. HCP reports that there were multiple doses given on unspecified dates to multiple patients.; This spontaneous report was received from a medical assistant concerning to an approximately 6-month-old (also reported as 7-month-old) male patient.  Information regarding the patient's pertinent medical history, concurrent conditions and concomitant medications was not provided.   On 19-SEP-2023, according to a digital data logger, there was a temperature excursion in clinical practice at 9:28, temperature was 8.3 Celsius degree and at 10:02 the temperature was 7.5 (units not provided) for a total excursion time of 34 minutes for Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) lot number reported as 1933911 (expiration date 18-APR-2024) and with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) lot  number reported as W001598 (expiration date 14-JAN-2024), albumin status was not provided, however, upon internal validation it was stablished as rHA. On 25-SEP-2023 at 11:08 temperature was at 9 Celsius degree and at 15:01 it was at 8.0 Celsius degree, for a total excursion time of 4 hours.  On 06-OCT-2023, the patient received the improperly stored Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) (strength, and route of administration were not provided) and the improperly stored Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (strength, and route of administration were not provided) (product administered to patient of inappropriate age) (product storage error) both of them administered as prophylaxis. It was reported that the patient received the vaccination in a private doctor's office.  No adverse effect was observed (no adverse event).     This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2311USA002926: US-009507513-2310USA010775: US-009507513-2311USA003147: US-009507513-2311USA002932: US-009507513-2311USA002931: US-009507513-2311USA002929: US-009507513-2311USA002930: US-009507513-2311USA002928:
No data provided. Annual follow up states speech difficulties still exist. Patient received speech therapy twice a week. Patient has other developmental problems such as unable to drink without a straw, cannot run normally and is not potty trained.
Headache, Myalgia, Fever, NauseaVomiting, CHILLS, RIGORS, HEADACHE, NAUSEA, BODY ACHES, FEVER 101.8 Narrative:
This spontaneous report was received from a registered nurse refers to a 38 year old patient. On 06-AUG-2013, the patient was vaccinated with an expired dose of 0.5 ml VARIVAX (Merck) (lot number reported as G00758, expiry date 04-AUG-2013, route not reported). Concomitant medications were not reported. No adverse effects reported. Additional information has been requested.
2nd dose of covid vaccine on 2/12/21, after known household exposure became symptomatic on 5/8/21 and tested positive for covid on  5/10/21.
Temperature of 101 approximately 12 hours after vaccination. Lasted overnight the first night. Fatigue 24-36 hours after vaccination. Back to normal 48 hours after vaccination.
This spontaneous report was received from a nurse and refers to a 1-year-old male patient. No information regarding the patient's concurrent conditions, medical history and concomitant therapies was reported. On 04-APR-2017, the patient received a properly stored dose of M-M-R II (albumin status rHA) (dose and route of administration were not provided), lot # L011528, expiration date 03-APR-2017. No adverse effects were reported. Additional information is not expected as there was no consent for further contact.
Fever after 1st dose; Chills after 1st dose; Headache after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache after 1st dose), CHILLS (Chills after 1st dose) and PYREXIA (Fever after 1st dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus, Chronic kidney disease and Hypertension. Concomitant products included INSULIN DEGLUDEC (TRESIBA FLEXTOUCH), DILTIAZEM, IRBESARTAN, CARVEDILOL, VITAMIN D NOS, ROSUVASTATIN CALCIUM (CRESTOR) and UBIDECARENONE (COQ10 [UBIDECARENONE]) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced HEADACHE (Headache after 1st dose). On 25-Feb-2021, the patient experienced CHILLS (Chills after 1st dose). On an unknown date, the patient experienced PYREXIA (Fever after 1st dose). At the time of the report, HEADACHE (Headache after 1st dose), CHILLS (Chills after 1st dose) and PYREXIA (Fever after 1st dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Dec-2021, Blood pressure measurement: normal (normal) EKG were okay. On 20-Dec-2021, Electrocardiogram: normal (normal) BP were okay.         No treatment medication were provided.   This case was linked to MOD-2021-420627 (Patient Link).
Arm Swollen primarily at shoulder but extending into tricep.  Redness to shoulder, arm, forearm.  Difficulty making fist.  Pain 6/10 to all joints in arm to fingers and R hip.
Pt. states after vaccination had headache, tired aches over body. Rash appeared on chest, back tops of arms. Site reaction with redness swelling. 9-02-11 pt. c/o of only rash still present today & just tired. Pt. instructed to use ice pack on arm for site rxn. & watch rash for 2 more days if no improvement contact PCP.
This spontaneous report was received from a pharmacist refers to a male patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route, anatomical location and lo # were not provided). Concomitant medications were not reported. On an unknown date and unspecified amount of time afterwards the patient was vaccinated, he was diagnosed with shingles. The patient sought medical attention. The physician stated that on unknown date the patient was treated for shingles and has since recovered. Additional information is not expected because reporter refused additional information contact.
p/vax pt reported pain @ inj site;pt was advised to be seen by MD but declined;pt recovered;
Sore injection site on first day, swelling of both arms on second day she took BENADRYL and Ibuprofen for pain.
Two Health Care employees were administered Pneumoccal vaccine, Pneumovax 23 (Merck) lot 1216J; exp 06/24/01. The 1st one developed cellulitis (left arm), treated with Keflex and later Augmentin. The temperature reached 103.2 for 2 1/2 days, also treated with Benadryl.
Patient received dose 2 of the Moderna vaccine 13 days early.  No adverse reaction occurred during 15 minute wait period. Attempted to contact patient  after discovering error. Patient did not answer phone.
On 6-27 after teaching my fitness class, while having a snack I had a horrible pain from my left eye socket to mid cheek. I iced, took an ALEVE, and went to bed, only to wake up with a bloody eye that turned out to be Iritis - side effect of shingles.
January 8th, I experienced flu like symptoms (aching, tiredness) which I understand this is normal. These symptoms lasted only aprox. four hours.  The other reaction, the one I am concerned about is that my bottom lip began to swell. The swelling continued throughout the night, swelling 3x normal size. It began to recede back to normal within 48 hours. Also, my lymph nodes under my right arm ( the injection arm) was very sore for 48 hours as well.
3/3/2017 at 1140am - Patient began to feel nauseous immediately following injection. Sat down and began to feel better so she returned to work. Began feeling dizzy after returning to office followed by jittery. Taken to blood drive after feeling better but then vomited. "Jittery, hot, lightheaded."
Developed a blood clot behind the left knee.  Symptoms started on 3/22/2021.  Saw physician on 03/23/2021 for tests and diagnosis
Besides expected minor side effects I got for the other vaccines, the day after I recieved the vaccine I got a raised, sore lump about 2" in diameter on my arm around the vaccination site  which seems to be getting slightly more tender a couple days later. It has not affected my life in any major way and I expect it to resolve itself
Patient was administered 0.3ml Covid 19 Immunization (pfizer) instead of 0.2ml peds Covid19 (pfizer) vaccination.  We tried notifying mom as quickly as we could when the error was detected. Patient had no know reaction.  We have attempted to reach family to f/u.
had one once and was very ill, flu or not was super sick; Initial information received on 14-Nov-2020 regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (consumer) via Social media.  This case involved an unknown age patient who reported that had one once and was very ill, flu or not was super sick (Illness), after receiving vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, unknown latency, after receiving vaccine the patient was very ill, flu or not was super sick (Illness).  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  The outcome of the event was unknown.  There will be no information available on the batch number for this case.
woke up sweating; felt like room was spinning; a bit dizzy; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 11Mar2021 at 11:15 (Lot Number: EN6205) (at the age of 67-year-old) as single dose for COVID-19 immunisation. The patient was not pregnant. The patient medical history was not reported. No known allergies.  The patient did not have COVID-19 before vaccination and not tested positive to COVID-19 since vaccination. Concomitant medications included atorvastatin at 20 mg; vitamin d [vitamin d nos] and xantofyl/zeaxanthin, all concomitants were taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 18Feb2021 at 12:15 (Lot Number: EL9267) (at the age of 67-year-old) as single dose for COVID-19 immunisation. On 12Mar2021 at 03:00 the patient woke up sweating and felt like room was spinning. Felt a bit better after a few hours but still a bit dizzy, particularly when turning head or standing. Felt fine at end of day but next day dizziness again. Not too bad but enough to make me avoid stooping for fear of getting dizzy when I stand up again. No therapeutic measures were taken as a result of the events. The patient outcome of the events was not recovered.    No follow-up attempts are possible. No further information is expected.